18.3 Social Determinants of Health, Health Literacy & Medication Access at ED Discharge

18.3 Social Determinants of Health, Health Literacy & Medication Access at ED Discharge

Why Social Determinants Matter in the ED

For many patients, the ED is their main point of contact with health care. An ideal prescription fails if the patient cannot afford it, cannot reach a pharmacy, cannot read the label, has nowhere to refrigerate it, or skips meals while taking a drug that lowers blood glucose. Social conditions drive return visits, readmissions and preventable deaths as much as drug choice does.

Healthy People 2030 Domains

Screening and Current Expectations

Common tools:

• The CMS Accountable Health Communities health-related social needs screening tool, with core questions on housing, food, transportation, utilities and interpersonal safety
• PRAPARE
• The two-question Hunger Vital Sign

Regulatory and accreditation status:

• CMS removed the hospital measures Screening for Social Drivers of Health and Screen Positive Rate for Social Drivers of Health from the Inpatient Quality Reporting program in the FY 2026 IPPS final rule.
• The Joint Commission's 2026 National Performance Goals still require hospitals to assess patients' health-related social needs and give information about community resources. Examples include transportation, difficulty paying for prescriptions, education and literacy, food insecurity and housing insecurity.
• The same goal requires hospitals to stratify quality data by sociodemographic characteristics and act on at least one identified disparity.

Screening is only useful when it leads to action: a social work referral, a community health worker, a cheaper drug or a medication delivered to the bedside.

Bias and Disparities

Studies of ED analgesia have repeatedly found that Black and Hispanic patients are less likely than White patients to receive opioid analgesia for the same painful conditions. Standardized pain protocols, order sets and audits of prescribing data stratified by patient group help reduce these unwarranted differences.

Cost and Insurance Barriers

• Ask directly, for example "How do you usually pay for your medicines, and is cost ever a problem?", and check prescription benefit information in the EHR when it is available.
• Medicare Part D: the Inflation Reduction Act created an annual out-of-pocket cap of $2,000 in 2025, rising to $2,100 in 2026, and the Medicare Prescription Payment Plan lets beneficiaries spread costs over the year. Covered insulin cost sharing is limited to $35 a month.
• Uninsured and underinsured patients:
  • Prefer drugs on low-cost generic lists.
  • Use manufacturer patient assistance programs. Copay cards cannot be used with Medicare or Medicaid.
  • Use the hospital's 340B program and charity care, and charitable vouchers.
• Prior authorization: for urgent drugs, choose a covered alternative or provide a bridge supply rather than send the patient home without therapy.

Practical Access Strategies at Discharge

Health Literacy, Numeracy and Language

National adult literacy data show that only about 12% of US adults have proficient health literacy. Many patients cannot use a dosing chart or a weight-based liquid dose correctly.

• Use plain language, the teach-back method, pictograms, and oral syringes marked in milliliters only (never teaspoons).
• Give written instructions in the patient's preferred language.
• Language access is a legal requirement: Title VI of the Civil Rights Act and Section 1557 of the Affordable Care Act require meaningful access, including qualified interpreters. The Joint Commission's 2026 goals include providing interpreting and translation services. Do not use family members, especially children, as interpreters for medication counseling.

Designing Regimens Around Patients' Circumstances

Homelessness and Unstable Housing

• Storage and theft: most insulin vials and pens can be kept at room temperature for about 28 days once opened (check the specific product). Smaller supplies and secure storage reduce theft of controlled substances.
• Long-acting therapies that avoid daily doses:
  • Dalbavancin (1,500 mg IV once, or 1,000 mg then 500 mg a week later) or oritavancin (1,200 mg IV once) for skin infections when completing oral antibiotics is unlikely.
  • Long-acting injectable antipsychotics.
  • Extended-release buprenorphine injections for opioid use disorder.
• Coordinate with shelters, street medicine teams and respite programs.

Food Insecurity

Insulin and sulfonylureas cause hypoglycemia when meals are skipped. Choose agents with lower hypoglycemia risk, reduce doses, and connect patients with food resources.

Substance Use Disorder

• ED-initiated buprenorphine doubles engagement in treatment at 30 days compared with referral alone (D'Onofrio, JAMA 2015).
• The federal X-waiver was eliminated in December 2022, so any practitioner with a Schedule III DEA registration can prescribe buprenorphine for opioid use disorder.
• DEA's 2023 rule allows practitioners to dispense up to a 3-day supply at once while arranging treatment (Section 18.4).
• Pair treatment with naloxone and harm reduction: syringe services, fentanyl test strips where legal, and peer recovery coaches.

Caregivers, Disability and Cognition

Involve caregivers in teaching, provide large-print labels and adherence aids, and confirm that the person who will give the medication, not just the patient, understands the plan.